BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

AnaSpec, Inc. Highlights Beta-Amyloid (1-42) Peptides


6/6/2012 12:29:47 PM

Fremont CA – June 6, 2012 -- Harnessing over a decade's worth of experience and a multi-level technology platform that includes peptides, antibodies, dyes and assay kits, AnaSpec, EGT Group is one of the world's most trusted sources of integrated proteomic solutions specifically designed for Alzheimer's Disease research.

Our large collection of ß-Amyloid (1-42) peptides includes: Native sequences – human and mouse/rat sequences (unless otherwise specified, sequences are human in origin)

Single or multiple amino acid substitution sequences, e.g. S26C

Biotin labeled sequences – N or C terminally labeled, with or without linker

Dye labeled sequences – HiLyte Fluor™ or classic dye labeled

ClearPoint™ heavy-isotope labeled sequences

Shorter sequences that end on the 42nd amino acid and analog

HFIP treated ß-Amyloid (1-42)

ß-Amyloid (Aß) peptides are generated as cleavage products 39 to 43 amino acids in length from the membrane protein, Amyloid Precursor Protein (APP) by two proteases, ß-secretase and ?-secretase.1-3 While only a small amount is processed by ß-Secretase, also known as BACE1 (ß-secretase APP cleaving enzyme) or memapsin, APP is predominantly processed by a-Secretase, producing a 83-amino acid C-terminal fragment, C83. Subsequent cleavage of C83 by ?-secretase produces a non-toxic N-terminal 3kD protein.1-2

Aßs are amphiphilic peptides with a hydrophilic N-terminal domain (residues 1 to 28) and a hydrophobic C-terminal (residues 29 to 40-42), the latter corresponding to a part of the transmembrane domain of APP.4 ß-Amyloid assembly into fibrils is initiated by a conformational transition from random coil to ß-sheet (hence the name ß-amyloid) and a nucleation-dependent aggregation process.4 Aß peptides that are 39 to 42 amino acid residues in length with a molecular mass of approximately 4 kDa are the core components of neuritic plaques seen in Alzheimer’s disease (AD) brains. The presence of excess amount of Aß deposits and neurofibrillary tangles, NFTs, 5-6 comprising of hyperphosphorylated Tau proteins are the hallmarks of an AD brain.1

Aß (1-42), a major component of amyloid plaques, accumulates in neurons of Alzheimer’s disease (AD) brains. Biochemical analysis of the amyloid peptides isolated from AD brain indicates that Aß (1-42) is the principal species associated with senile plaque amyloids, while Aß (1-40) is more abundant in cerebrovascular amyloid deposit.7-8

References:

1. Selkoe DJ. Nature 399, A23 (1999).

2. Suh, Y-H. and F. Checler, Pharmacol Rev 54, 469 (2002).

3. Kang, J. et al. Nature 325, 733 (1987).

4. Jarrett, JT. et al. Biochem 32, 4693 (1993).

5. Masters, CL. et al. EMBO J 4, 2757 (1985).

6. Braak, H. et al. Acta Neuropathol 87, 554 (1994).

7. Nagele, R. et al. Neurosci 110, 199 (2002).

8. Garzon-Rodriguez, W. et al. J Biol Chem 272, 21037 (1997).

For more information, please visit http://www.anaspec.com/products/promotions.asp?id=101&col=2&row=1

AnaSpec, EGT Group

AnaSpec, Eurogentec Group is a leading provider of integrated proteomics and genomics solutionsTM for worldwide life science research. AnaSpec offers expertise in peptides, detection reagents, antibodies, assay kits, amino acids, oligonucleotides, and qPCRs. AnaSpec carries a broad product line of biochemicals and reagents for basic research, high-throughput screening and drug discovery. AnaSpec also provides premier custom services including peptide synthesis, antibody production, assay development, fluorescent dyes, and oligonucleotide synthesis. AnaSpec is certified to ISO 9001:2008.

For more information visit www.anaspec.com


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->